Article
Adacolumn treatment in kidney transplant patients with hepatitis C virus.
Transplantation proceedings - 1 May 2009
Novelli G, Rossi M, Ferretti G, Poli L, Pretagostini R, Ruberto F, Morabito V, Cinti P, Nudo F, Mennini G, Berloco P B
Abstract excerpt
INTRODUCTION: Patients who have undergone kidney transplantation and suffer from hepatitis C (HCV) cannot be treated with standard therapy (pegylated interferon combined with ribavirin) due to the risk of acute rejection. Furthermore, immunosuppressive therapy facilitates the progression of infection and chronic hepatopathies. Monocytes and macrophages are known to produce extrahepatic breeding sites that spread...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.